CNS–Immune Reconstitution Inflammatory Syndrome in the Setting of HIV Infection, Part 2: Discussion of Neuro–Immune Reconstitution Inflammatory Syndrome with and without Other Pathogens

REFERENCES

1. 1.↵
   1. Johnson T,
   2. Nath A

   . Neurological complications of immune reconstitution in HIV-infected populations. Ann N Y Acad Sci 2010;1184:106–20

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Shelburne SA,
   2. Visnegarwala F,
   3. Darcourt J,
   4. et al

   . Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005;19:399–406

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Shelburne SA III.,
   2. Hamill R

   . The immune reconstitution inflammatory syndrome. AIDS Rev 2003;5:67–79

   PubMed
4. 4.↵
   1. Shelburne SA,
   2. Montes M,
   3. Hamill RJ

   . Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006;57:167–70

   Abstract/FREE Full Text
5. 5.↵
   1. Muller M,
   2. Wandel S,
   3. Colebunders R,
   4. et al

   . Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:251–61

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Vendrely A,
   2. Bienvenu B,
   3. Gasnault J,
   4. et al

   . Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005;109:449–55

   CrossRefPubMed
7. 7.↵
   1. Shelburne SA III.,
   2. Hamill RJ,
   3. Rodriquez-Barradas MC,
   4. et al

   . Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002;81:213–27

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Bonham S,
   2. Meya DB,
   3. Bohjanen PR,
   4. et al

   . Biomarkers of HIV immune reconstitution inflammatory syndrome. Biomark Med 2008;2:349–61

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Manabe Y,
   2. Campbell JD,
   3. Syndor E,
   4. et al

   . Immune reconstitution inflammatory syndrome: risk factors and treatment applications. J Acquir Immune Defic Syndr 2007;46:456–62

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Grant PM,
    2. Komarow L,
    3. Andersen J,
    4. et al

    . Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS ONE 2010; 5:e11416

    CrossRefPubMed
11. 11.↵
    1. Dhasmana DJ,
    2. Dheda K,
    3. Ravn P,
    4. et al

    . Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs 2008;68:191–208

    CrossRefPubMedWeb of Science
12. 12.↵
    1. French MA

    . Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Curr HIV/AIDS Rep 2007;4:16–21

    CrossRefPubMed
13. 13.↵
    1. French MA,
    2. Lenzo N,
    3. John M,
    4. et al

    . Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000;1:107–15

    CrossRefPubMed
14. 14.↵
    1. French MA

    . Immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009;48:101–07

    Abstract/FREE Full Text
15. 15.↵
    1. Tan K,
    2. Roda R,
    3. Ostrow L,
    4. et al

    . PML-IRIS in patients with HIV infection. Clinical manifestations and treatment with steroids. Neurology 2009;72:1458–64

    CrossRef
16. 16.↵
    1. Berkeley JL,
    2. Nath A,
    3. Pardo CA

    . Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: case report and review of the literature. J Neurovirol 2008;14:267–76

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Navas E,
    2. Martin-Davilla P,
    3. Moreno L,
    4. et al

    . Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Inn Med 2002;162:97–99

    CrossRef
18. 18.↵
    1. Murdoch DM,
    2. Venter WDF,
    3. Van Rie A,
    4. et al

    . Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007;4:1–10

    CrossRefPubMed
19. 19.↵
    1. Riedel DJ,
    2. Pardo CA,
    3. McArthur J,
    4. et al

    . Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Prac Neurol 2006;2:557–65

    CrossRef
20. 20.↵
    1. Bicanic T,
    2. Meintjes G,
    3. Rebe K,
    4. et al

    . Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009;51:130–34

    CrossRefPubMedWeb of Science
21. 21.↵
    1. McCombe JA,
    2. Auer RN,
    3. Maingat FG,
    4. et al

    . Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology. Neurology 2009;72:835–41

    CrossRef
22. 22.↵
    1. Venkataramana A,
    2. Pardo CA,
    3. McArthur JC,
    4. et al

    . Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 2006;67:383–88

    CrossRef
23. 23.↵
    1. Gray F,
    2. Bazille C,
    3. Biassette-Adle,
    4. et al

    . Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 2005;11:16–22

    CrossRefPubMedWeb of Science
24. 24.↵
    1. van der Ven AJ,
    2. van Oostenbrugge RJ,
    3. Kubat B,
    4. et al

    . Cerebral vasculitis after initiation antiretroviral therapy. AIDS 2002;16:2362–64

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Murdoch DM,
    2. Venter WDF,
    3. Feldman C,
    4. et al

    . Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008;22:601–10

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Robertson J,
    2. Meier M,
    3. Wall J,
    4. et al

    . Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infec Dis 2006;42:1639–46

    Abstract/FREE Full Text
27. 27.↵
    1. Stoll M,
    2. Schmidt RE

    . Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. Curr HIV/AIDS Rep 2004;1:122–27

    CrossRefPubMed
28. 28.↵
    1. Singer EJ,
    2. Sueiras-Valdes M,
    3. Commins D,
    4. et al

    . Neurologic presentations of AIDS. Neurol Clin 2010;28:253–75

    CrossRefPubMed
29. 29.↵
    1. Sexton DJ,
    2. Pien BC,
    3. et al

    . Immune reconstitution inflammatory syndrome. UpToDate. Available at http://www.uptodate.com. Accessed January 31, 2012
30. 30.↵
    1. McCarthy M,
    2. Nath A

    . Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS). Curr Neurol Neurosci Rep 2010;10:467–75

    CrossRefPubMed
31. 31.↵
    1. McArthur JC,
    2. Steiner J,
    3. Sacktor N,
    4. et al

    . Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 2010;67:699–714

    CrossRefPubMedWeb of Science
32. 32.↵
    1. DeSimone JA,
    2. Pomerantz RJ,
    3. Babinchak TJ

    . Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000;133:447–54

    CrossRefPubMedWeb of Science
33. 33.↵
    1. French MA,
    2. Mallal SA,
    3. Dawkins RL

    . Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992;6:1293–97

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Ohta K,
    2. Kishida S

    . Immune reconstitution inflammatory syndrome in the central nervous system. Brain Nerve 2007;59:1355–62

    PubMed
35. 35.↵
    1. Rushing EJ,
    2. Liappis A,
    3. Smirniotopoulos JD,
    4. et al

    . Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity. J Neuropathol 2008;67:819–27

    CrossRefPubMed
36. 36.↵
    1. Nath A,
    2. Geiger J

    . Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 1998;54:19–33

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Navdeesh S,
    2. McCutchan JA

    . Unmasking of PML by HAART: unusual clinical features and the role of IRIS. J Neuroimmunol 2010;219:100–04

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Teo EC,
    2. Azwra A,
    3. Jones R,
    4. et al

    . Guillain-Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection. J HIV Ther 2007;12:62–63

    PubMed
39. 39.↵
    1. Paul RH,
    2. Sacktor NC,
    3. Valcour V,
    4. et al.

    1. Anthony IC,
    2. Bell JE

    . Neuropathological findings associated with long-term HAART. In: Paul RH, Sacktor NC, Valcour V, et al., eds. HIV and the Brain. New Challenges in the Modern Era. New York: Humana Press; 2009:29–47
40. 40.↵
    1. Bazille GF,
    2. Biassette MH,
    3. Moulignier A,
    4. et al

    . Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 2005;3:16–22
41. 41.↵
    1. Ratnam I,
    2. Chiu C,
    3. Kandala NB,
    4. et al

    . Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418–27

    Abstract/FREE Full Text
42. 42.↵
    1. Huruy K,
    2. Andargachew M,
    3. Getahun M,
    4. et al

    . Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia. J Infect Dis 2008;61:205–09
43. 43.↵
    1. Gray F,
    2. Chrétien F,
    3. Vallat-Decouvelaere AV,
    4. et al

    . The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 2003;62:429–40

    PubMedWeb of Science
44. 44.↵
    1. Price P,
    2. Morahan G,
    3. Huang D,
    4. et al

    . Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002;16:2043–47

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Wang ME,
    2. Castillo ME,
    3. Silvia M,
    4. et al

    . Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru. Pediatr Infect Dis J 2009;28:900–03

    CrossRefPubMed
46. 46.↵
    1. Kilborn T,
    2. Zampoli M

    . Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIV-infected children. Pediatr Radiol 2009;39:569–74

    CrossRefPubMed
47. 47.↵
    1. Newsome SD,
    2. Nath A

    . Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol 2009;15:288–91

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Nagel MA,
    2. Cohrs RJ,
    3. Mahalingam R,
    4. et al

    . The varicella zoster vasculopathies: clinical, CSF, imaging and virologic features. Neurology 2008;70:853–59

    CrossRef
49. 49.↵
    1. Nanavati KI,
    2. Post MJ,
    3. Nagornaya N

    . Value of MRI in the diagnosis of clinically elusive herpes zoster myelitis in HIV-positive patients. In: Proceedings of the American Society of Spine Radiology Annual Symposium, Miami Beach, Florida. February 18–22, 2009
50. 50.↵
    1. Espinosa E,
    2. Pena-Jimenez A,
    3. Ormsby CE,
    4. et al

    . Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome. HIV Med 2009;10:454–57

    CrossRefPubMed
51. 51.↵
    1. Steininger C,
    2. Puchhammer-Stocki E,
    3. Popow-Kraupp

    . Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). J Clin Virol 2006;37:1–9

    CrossRefPubMedWeb of Science
52. 52.↵
    1. Karavellas MP,
    2. Lowder CY,
    3. MacDonald C,
    4. et al

    . Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998;116:169–75

    PubMedWeb of Science
53. 53.↵
    1. Jacobson MA,
    2. Zegans,
    3. Pavan PR,
    4. et al

    . Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443–45

    CrossRefPubMedWeb of Science
54. 54.↵
    1. Anderson AM,
    2. Mosunjac MB,
    3. Corey AS,
    4. et al

    . Simultaneous typical and extraordinary imaging findings of AIDS-associated cytomegalovirus encephalitis. J Neurol Sci 2011;307:174–77

    CrossRefPubMed
55. 55.↵
    1. Anderson AM,
    2. Fountain JA,
    3. Green SB,
    4. et al

    . Human immunodeficiency virus-associated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution. J Neurovirol 2010;16:179–84

    CrossRefPubMedWeb of Science
56. 56.↵
    1. Morgello S.,
    2. Cho ES,
    3. Nielsen S,
    4. et al

    . Cytomegalovirus encephalitis in patients with the acquired immunodeficiency syndrome: an autopsy of 30 cases and a review of the literature. Hum Pathol 1987;18:289–97

    PubMedWeb of Science
57. 57.↵
    1. Melica G,
    2. Brugieres P,
    3. Lascaux AS,
    4. et al

    . Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era. J Med Virol 2009;81:578–81

    CrossRefPubMed
58. 58.↵
    1. Thurnher MM,
    2. Schindler EG,
    3. Thurnher SA,
    4. et al

    . Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MRI imaging findings and clinical course. AJNR Am J Neuroradiol 2000;21:670–78

    Abstract/FREE Full Text
59. 59.↵
    1. Miller RF,
    2. Issacson PG,
    3. Hall-Craggs M,
    4. et al

    . Cerebral CD8 lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 2004;108:17–23

    CrossRefPubMedWeb of Science
60. 60.↵
    1. Langford TD,
    2. Letendre SL,
    3. Marcotte TD,
    4. et al

    . Severe demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002;16:1019–29

    CrossRefPubMedWeb of Science
61. 61.↵
    1. Tavazzi E,
    2. Bargiggia V,
    3. Pichiecchio A,
    4. et al

    . HIV-related acute inflammatory leukoencephalopathy of undetermined origin: review of the literature. Int J Immunopathol Pharmacol 2010;23:693–700

    Abstract/FREE Full Text
62. 62.↵
    1. Kishida S,
    2. Ajisawa A

    . Probable cerebral mycobacterium avium complex-related immune reconstitution inflammatory syndrome in an HIV-infected patient. Intern Med 2008;47:1349–54

    CrossRefPubMedWeb of Science
63. 63.↵
    1. Mohanty K

    . Immune reconstitution inflammatory syndrome after initiation of highly active anti-retroviral therapy in HIV/AIDS. Indian J Dermatol Venereol Leprol 2010;76:301–04

    CrossRefPubMed
64. 64.↵
    1. Murray R,
    2. Mallal S,
    3. Heath C,
    4. et al

    . Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection. Eur J Clin Microbiol Infect Dis 2001;20:199

    CrossRefPubMedWeb of Science
65. 65.↵
    1. Breton G,
    2. Duval X,
    3. Estellat C,
    4. et al

    . Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004;39:1709–12

    Abstract/FREE Full Text
66. 66.↵
    1. Pepper DJ,
    2. Marais S,
    3. Maartens G,
    4. et al

    . Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009;48:e96–107

    Abstract/FREE Full Text
67. 67.↵
    1. Marais S,
    2. Pepper DJ,
    3. Marais B,
    4. et al

    . HIV-associated tuberculous meningitis: diagnostic and therapeutic challenges. Tuberculosis (Edinb) 2010;90:364–74
68. 68.↵
    1. Thwaites GE,
    2. Macmullen-Price J,
    3. Tran TH,
    4. et al

    . Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007;6:230–36

    CrossRefPubMedWeb of Science
69. 69.↵
    1. Whiteman M,
    2. Espinoza L,
    3. Post MJ,
    4. et al

    . CNS tuberculosis in HIV-infected patients: clinical and radiographic findings. AJNR Am J Neuroradiol 1995;16:1319–27

    Abstract
70. 70.↵
    1. Tsambiras PE,
    2. Larkin JA,
    3. Houston SH

    . Case report: toxoplasma encephalitis after initiation of HAART. AIDS Read 2001;11:615–16
71. 71.↵
    1. Ledergerber B,
    2. Egger M,
    3. Erard V,
    4. et al

    . AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV cohort study. JAMA 1999;282:2220–26

    CrossRefPubMedWeb of Science
72. 72.↵
    1. Balkhair A,
    2. Ahamed S,
    3. Sankhla D

    . Unmasking immune reconstitution inflammatory syndrome (IRIS): A report of five cases and review of the literature. Sultan Qaboos Univ Med J 2011;11:95–103

    PubMed
73. 73.↵
    1. Tremont-Lukats IW,
    2. Garciarena P,
    3. Juarbe R,
    4. et al

    . The immune inflammatory reconstitution syndrome and central nervous system toxoplasmosis. Ann Intern Med 2009;150:656–57

    CrossRefPubMed
74. 74.↵
    1. Pfeffer G,
    2. Prout A,
    3. Hooge J,
    4. et al

    . Biopsy-proven immune reconstitution syndrome in a patient with AIDS and cerebral toxoplasmosis. Neurology 2009;73:321–22

    CrossRef
75. 75.↵
    1. Rodriguez RR,
    2. Sorlano V,
    3. Dona C,
    4. et al

    . Opportunistic infections shortly after beginning highly active antiretroviral therapy. Antivir Ther 1998;3:229–31

    PubMedWeb of Science
76. 76.↵
    1. Martin-Blondel G,
    2. Alvarez M,
    3. Delobel P,
    4. et al

    . Toxoplasmic encephalitis IR IS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry 2010;8:691
77. 77.↵
    1. Costello DJ,
    2. Gonzalez RG,
    3. Frosch MP

    . Case 18–2011: a 35-year-old HIV-positive woman with headache and altered mental status. N Engl J Med 2011;364:2343–52

    CrossRefPubMed
78. 78.↵
    1. Lindzen E,
    2. Jewells V,
    3. Bouldin T,
    4. et al

    . Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy. J Neurovirol 2008;14:569–73

    CrossRefPubMedWeb of Science
79. 79.↵
    1. Oelschlaeger C,
    2. Dziewas R,
    3. Reichelt D,
    4. et al

    . Severe leukoencephalopathy with fulminant cerebral edema reflecting immune reconstitution inflammatory syndrome during HIV infection: a case report. J Med Case Reports 2010;4:214–16

    CrossRefPubMed